Drugs News and Research

RSS

Researchers claim AI could produce protein molecules

Researchers claim AI could produce protein molecules

Machine learning has completely changed protein structure prediction over the past two years. A comparable revolution in protein design is now described in three studies published in Science.

16 Sep 2022

Encouraging breakthroughs in eliminating therapy-resistant cancer cells

Encouraging breakthroughs in eliminating therapy-resistant cancer cells

The human immune system is notably adept at evading tumor cells, which construct physical barriers, adopt masks, and restrain the immune system with molecular ploys.

14 Sep 2022

Using human saliva to treat infections that are resistant to antibiotics

Using human saliva to treat infections that are resistant to antibiotics

Tens of millions of individuals throughout the world suffer from antibiotic resistance every year. The CDC reports that more than 35,000 people die each year as a result of more than 2.8 million antibiotic-resistant infections that take place there each year.

2 Sep 2022

Yeast platform for the production of plant-derived anti-cancer drug

Yeast platform for the production of plant-derived anti-cancer drug

The supply of a plant-derived anti-cancer drug can finally meet global demand after a team of scientists from Denmark and the U.S. engineered yeast to produce the precursor molecules, which could previously only be obtained in trace concentrations in the native plant.

1 Sep 2022

Diseased connective tissue cells alter the physical structure of their genomes

Diseased connective tissue cells alter the physical structure of their genomes

Researchers at Penn Medicine have found that when cells are impacted by the disease, the physical structure of their genome changes.

25 Aug 2022

Extract from the roots of Rhodiola rosea may be effective for managing type 2 diabetes

Extract from the roots of Rhodiola rosea may be effective for managing type 2 diabetes

A team of researchers led by the University of California, Irvine has discovered that treatment with an extract from the roots of the Rhodiola rosea plant might be effective for helping manage type 2 diabetes, showing promise as a safe and effective non-pharmaceutical alternative.

16 Aug 2022

Inventia Life Science Accelerates Growth with AU$35 million Series B Led by Blackbird Ventures, Launching 3D Cell Culture Platform into US Market

Inventia Life Science Accelerates Growth with AU$35 million Series B Led by Blackbird Ventures, Launching 3D Cell Culture Platform into US Market

Company aims to democratise access to affordable biomedical research especially in cancer research and new drug development through its novel 3D cell culture platform

From Inventia Life Science 16 Aug 2022

Australian company accelerating the speed of drug discovery wins prestigious Eureka prize

Australian company accelerating the speed of drug discovery wins prestigious Eureka prize

Inventia Life Science announced that its RASTRUM™ 3D cell culture platform has won the ANSTO Eureka Prize for Innovative Use of Technology at the 2021 Australian Museum Eureka Prizes.

From Inventia Life Science 16 Aug 2022

Inventia Life Science partners with Xylyx Bio to develop tissue-specific, digitally-printed bioinks for drug discovery

Inventia Life Science partners with Xylyx Bio to develop tissue-specific, digitally-printed bioinks for drug discovery

Inventia Life Science and Xylyx Bio today announced their strategic partnership following promising results developing more realistic, scalable, and reproducible 3D cell cultures for drug discovery and biomedical research.

From Inventia Life Science 16 Aug 2022

RASTRUM™ - the 3D Printer of Living Cells, Honored in Annual Awards by Leading Business Magazine

RASTRUM™ - the 3D Printer of Living Cells, Honored in Annual Awards by Leading Business Magazine

RASTRUM™ has taken out the top prize in the Experimental category. RASTRUM™ prints human cells into living tissue models to supercharge research into cancer and other diseases using revolutionary drop-on-demand technology.

From Inventia Life Science 16 Aug 2022

Inventia Life Science Announces Partnership with PhenoVista Biosciences to Accelerate Preclinical Research with 3D Cell Models

Inventia Life Science Announces Partnership with PhenoVista Biosciences to Accelerate Preclinical Research with 3D Cell Models

Inventia Life Science, a leader in automated generation of complex 3D cell models, and PhenoVista Biosciences, a top provider of custom imaging-based phenotypic assay services, have entered into a partnership to deliver high-content cell-based assay services for drug discovery.

From Inventia Life Science 16 Aug 2022

Fabimycin likely to be an effective treatment for drug-resistant bacteria

Fabimycin likely to be an effective treatment for drug-resistant bacteria

Bacteria that cause urinary tract infections are getting more and more resistant to many medications, and they are becoming more and more difficult to cure.

12 Aug 2022

SLFN11’s surveillance part in protein homeostasis

SLFN11’s surveillance part in protein homeostasis

On July 25th, 2022, a new study perspective called “SLFN11’s surveillance role in protein homeostasis” was published in Volume 9 of Oncoscience.

8 Aug 2022

Novel model system to identify new treatments for CF patients who continue to struggle without therapies

Novel model system to identify new treatments for CF patients who continue to struggle without therapies

A mutation in the CFTR gene results in cystic fibrosis (CF). Despite the fact that there are many hundreds of identified mutations, not all of them can now be treated, leaving a sizable portion of CF patients without access to targeted medicines.

3 Aug 2022

Scientists solve how RNA molecules reach their targets

Scientists solve how RNA molecules reach their targets

Scientists claim that life does not come with an instruction manual, but this is not totally accurate. Each cell in our body follows the instructions provided by its DNA in the form of RNA molecules.

1 Aug 2022

Genomics plays a major role in psychedelic drugs behavior

Genomics plays a major role in psychedelic drugs behavior

It can be crippling for those who suffer from conditions like depression, anxiety, and cluster headaches. In clinical research, psychedelic substances have demonstrated benefits as therapies for several ailments, but not in all cases.

1 Aug 2022

Antibiotics can affect gut microbiomes distinctly, a new study reveals

Antibiotics can affect gut microbiomes distinctly, a new study reveals

Scientists at Cedars-Sinai discovered that antibiotics have sex-specific effects on the gut microbiome makeup of male and female laboratory rats in a new study.

22 Jul 2022

High-throughput, model-guided approach for rationally tuning site-specific recombination reaction

High-throughput, model-guided approach for rationally tuning site-specific recombination reaction

Researchers from the University of Minnesota Twin Cities have, for the first time, created a novel tool to predict and customize the rate of a particular kind of DNA editing known as “site-specific recombination.”

22 Jul 2022

Research outlines how stem cells become sensory interneurons

Research outlines how stem cells become sensory interneurons

In a first-of-its-kind blueprint, scientists have shown how stem cells mature into sensory interneurons, which are responsible for feelings including touch, pain, and itching.

22 Jul 2022

New research shows protein movements play an important role in their ability to function

New research shows protein movements play an important role in their ability to function

Researchers at Johns Hopkins Medicine have reported that they have interrogated the atomic structure of proteins, adding to proof that the wobbles, shakes, and quivers of proteins play an important role in their ability to operate.

18 Jul 2022

Previous
1
...
23
24
25
26
27
28
29
...
84
Next

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.